Immatics
IMTX
#5279
Rank
โ‚ฌ1.36 B
Marketcap
10,01ย โ‚ฌ
Share price
5.06%
Change (1 day)
118.99%
Change (1 year)

Revenue for Immatics (IMTX)

Revenue in 2025 (TTM): โ‚ฌ48.26 Million

According to Immatics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.38 Million. a decrease over the revenue in the year 2024 that were of โ‚ฌ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immatics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ48.26 M-69.03%
2024 โ‚ฌ0.15 B188.6%
2023 โ‚ฌ53.99 M-68.76%
2022 โ‚ฌ0.17 B397.18%
2021 โ‚ฌ34.76 M11.23%
2020 โ‚ฌ31.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚ฌ0.11 B 152.97%๐Ÿ‡บ๐Ÿ‡ธ USA